СПИСОК ЛИТЕРАТУРЫ
СПИСОК ЛИТЕРАТУРЫ
Глава 1
Amen, D. G. 2005. Making a Good Brain Great. New York: Harmony Books.
Amen, D. G., C. Hanks, J. R. Prunella, et al. 2007. An analysis of regional cerebral blood flow in impulsive murderers using single photon emission computed tomography. Journal of Neuropsychiatry and Clinical Neuroscience 19(3): 304–309.
Gilbert, S. 2005. Married with problems? Therapy may not help. New York Times. April 19. http://www.nytimes.com/2005/04/19/health/ psychology/19coup.html?r= 1 &oref=slogin.
Глава 2
Adams, J., С. M. Adler, K. Jarvis, et al. 2007. Evidence of anterior temporal atrophy in college — level soccer players. Clinical Journal of Sport Medicine 17(4): 304–306.
Feldman, H. A., I. Goldstein, D. G. Hatzichristou, et al. 1994. Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study. Journal of Urology 151: 54–61.
Firlik, K. Another Day in the Frontal Lobe: A Brain Surgeon Exposes Life on the Inside. New York: Random House.
Глава 3
Amen, D. G. and J. Payne. Making a Good Brain Great High School Course, 2005.
http://amenclinics.com/store/index.php?mainpage=productinfo&cPath=6&productsid=39.
Anderson, С. A. and К. Е. Dill. 2000. Video games and aggressive thoughts, feelings, and behavior in the laboratory and in life. Journal of Personality and Social Psychology 78(4): 772–790.
Bartholow, B. D., M. A. Sestir and E. B. Davis. 2005. Correlates and consequences of exposure to video game violence: hostile personality, empathy, and aggressive behavior. Personality and Social Psychology Bulletin 2005 Nov 31(11): 1573–1586.
Ding, J., M. L. Eigenbrodt, T. H. Mosley, Jr., et al. 2003. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community- based population of middle- aged adults: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 35(1): 16–21.
Hancox, R. J., B. J. Milne, and R. Poulton. 2004. Association between child and adolescent television viewing and adult health: A longitudinal birth cohort study. Lancet 364(9430): 257–262.
Lindstrom, H. A., T. Fritsch, G. Petot, et al. 2005. The relationships between television viewing in midlife and the development of Alzheimer’s disease in a casecontrol study. Brain and Cognition 58(2): 157-65.
Park, R. M., P. A. Schulte, J. D. Bowman, et al. 2005. Potential occupational risks for neurodegenerative diseases. American Journal of Industrial Medicine 48(1): 63–77.
Wilson, G. D. http://www.cnn.com/2005/WORLD/europe/04/22/text.iq/.
Глава 4
Amen, D. G. 2000. Change Your Brain, Change Your Life. 2000. New York: Three Rivers Press.
Kessler, R. С, P. A. Berglund, O. Dernier, et al. 2005. Lifetime prevalence and ageof-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry 62(6): 593–602.
Глава 5
Поливитамины
Fairfield, К. М., and R. Н. Fletcher. 2002. Vitamins for chronic disease prevention in adults: Scientific review. Journal of the American Medical Association 287(23): 3116–3126.
Fletcher, R. H., and К. M. Fairfield. 2002. Vitamins for chronic disease prevention in adults: Clinical applications. Journal of the American Medical Association 287(23): 3127–3129.
Жирные кислоты омега-3/рыбий жир
Appel, L. J., Е. R. Miller III, A. J. Seidler, et al. 1993. Does supplementation of diet with «fish oil» reduce blood pressure? A meta-analysis of controlled clinical trials. Archives of Internal Medicine 153(12): 1429–1438.
Hiroshima, F., A. M. Parow, A. L. Stoll, et al. 2004. Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. American Journal of Psychiatry 161(10): 1922–1924.
Stoll, A. L., К. E. Damico, B. P. Daly, et al. 2001. Methodological considerations in clinical studies of omega-3 fatty acids in major depression and bipolar disorder. World Review of Nutrition and Dietetics 88: 58–67.
Глава 6
СДВ
Amen, D. G. 2001. Healing ADD: The Breakthrough Program That Allows You to See and Heal the 6 Types of ADD. New York: Putnam.
Benton, D., and G. Roberts. 1988. Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren. Lancet 1(8578): 140–143.
McCann, D., A. Barrett, A. Cooper, et al. 2007. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double- blinded, placebo- controlled trial. Lancet 370(9598): 1560–1567.
Pelsser, L. M., K. Frankena, J. Toorman, et al. A randomised controlled trial into the effects of food on ADHD. European Child & Adolescent Psychiatry.
Жирные кислоты омега-3/рыбий жир
Colter, A. L, С. Cutler, and К. A. Meckling. 2008. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a casecontrol study. Nutrition Journal 7: 8.
Johnson, M., S. Ostlund, G. Fransson, et al. Omega-3/Omega-6 fatty acids for attention deficit hyperactivity disorder: A randomized placebo-controlled trial in children and adolescents. Journal of Attention Disorders.
Richardson, A. J., and P. Montgomery. 2005. The Oxford- Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115(5): 1360–1366.
Ацетил-L-карнитин
Arnold, L. E., A. Amato, H. Bozzolo, et al. Acetyl-L-carnitine (ALC) in attentiondeficit / hyperactivity disorder: A multi- site, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology 17(6): 791–802.
Bianchetti, A., R. Rozzini, and M. Trabucchi. 1992. Effects of acetyl- L-carnitine in Alzheimer’s disease patients unresponsive to acetylcholinesterase inhibitors. Current Medical Research and Opinion 19(4): 350–353.
Bowman, B. 1992. Acetyl- carnitine and Alzheimer’s disease. Nutrition Reviews 50: 142–144.
Rossini, М., О. Di Munno, G. Valentini, et al. 2007. Double-blind, multicenter trial comparing acetyl- L- carnitine with placebo in the treatment of fibromyalgia patients. Clinical and Experimental Rheumatology 25(2): 182–188.
Tempesta, E., L. Casella, C. Pirrongelli, et al. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs. placebo. Drugs Under Experimental 8c Clinical Research 13(7): 417–423.
DL-фенилаланин
Baker, G. B., R. A. Bornstein, A. C. Rouget, et al. 1991. Phenylethylamin-ergic mechanisms in attention- deficit disorder. Biological Psychiatry 29(1): 15–22.
Beckmann, H., M. A. Strauss, and E. Ludolph. 1977. DL- phenylalanine in depressed patients: An open study. Journal of Neural Transmission 41(2–3): 123–134.
Walsh, N. E., S. Ramamurthy, L. Schoenfeld, et al. 1986. Analgesic effectiveness of
ГАМК
Abdou, A. M., S. Higashiguchi, K. Horie, et al. 2006. Relaxation and immunity enhancement effects of gamma- aminobutyric acid (GABA) administration in humans. Biofactors 26(3): 201–208.
Chovanova, Z., J. Muchova, M. Sivonova, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8- oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radical Research 40(9): 1003–1010.
Dvorakova, M., M. Sivonova, J. Trebaticka, et al. 2006. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Report 11(4): 163–172.
L-тирозин
Chiaroni, P., J. М. Azorin, Р. Bovier, et al. 1990. A multivariate analysis of red blood cell membrane transports and plasma levels ot L- tyrosine and L- tryptophan in depressed patients before treatment and after clinical improvement. Neuropsychobiology 23(1): 1–7.
Kelly, G. S. 1999. Nutritional and botanical interventions to assist with the adaptation to stress. Alternative Medicine Review 4(4): 249–265.
Meyers, S. 2000. Use of neurotransmitter precursors for treatment of depression. Alternative Medicine Review 5(1): 64–71.
Wagenmakers, A. J. 1999. Amino acid supplements to improve athletic performance. Current Opinion in Clinical Nutrition and Metabolic Care 2(6): 539–544.
S-аденозилметионин (SAMe)
Baldessarini, R. J. 1987. Neuropharmacology of S- adenosyl- L- methionine. American Journal of Medicine 83(5A): 95-103.
Bell, К. M., et al. 1994. S- adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurologica Scandi-navica Supplement 154: 15–18.
Fava, M., A. Giannelli, V. Rapisarda, et al. 1995. Rapidity of onset of the antidepressant effect of parenteral S- adenosyl- L- methionine. Psychiatry Research 56(3): 295–297.
Gaby, A. R. 1999. Natural treatments for osteoarthritis. Alternative Medicine Review 4(5): 330–341.
Konig, B. 1987. A long-term (two years) clinical trial with S- adenosylmethionine for the treatment of osteoarthritis. American Journal of Medicine 83(5A): 89–94.
Leventhal, L. J. 1999. Management of fibromyalgia. Annals of Internal Medicine 131: 850–858.
Зверобой
Behnke, К., G. S. Jensen, Н. J. Graubaum, et al. 2002. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Advances in Therapy 19(1): 43–52.
Brenner, R., V. Azbel, S. Madhusoodanan, et al. 2000. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A doubleblind, randomized pilot study. Clinical Therapeutics 22(4): 411–419.
Kalb, R., R. D. Trautmann- Sponsel, and M. Kieser. 2001. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double- blind multicenter clinical trial. Pharmacopsychiatry 34(3): 96-103.
Simeon, J., M. Nixon, R. Milin, et al. 2005. Open- label pilot study of St. Johns wort in adolescent depression. Journal of Child & Adolescent Psychopharmacology 15(2): 293–301.
Теанин
Bryan, J. 2008. Psychological effects of dietary components of tea: caffeine and Ltheanine. Nutrition Review 66(2): 82–90.
Dimpfel, W., A. Kler, E. Kriesl, et al. 2007. Source density analysis of the human EEG after ingestion of a drink containing decaffeinated extract of green tea enriched with L- theanine and theogallin. Nutritional Neuroscience 10(3–4): 169–180.
Nobre, A. C., A. Rao, and G. N. Owen. 2008. L- theanine, a natural constituent in tea, and its effect on mental state. Asia Pacific Journal of Clinical Nutrition 17(Suppl. 1): 167–168.
Rogers, P. J., J. E. Smith, S. V: Heatherley, et al. 2008. Time for tea: Mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology 195(4): 569–577.
Цинк
Arnold, L. Е., Н. Bozzolo, J. Hollway, et al. 2005. Serum zinc correlates with parent- and teacher- rated inattention in children with attention- deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology 15(4): 628–636.
Bilici, M., F. Yildirim, S. Kandil, et al. 2004. Double- blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 28(1): 181–190.
Yorbik, O., M. F. Ozdag, A. Olgun, et al. 2008. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 32(3): 662–667.
Глава 7
Amen, D. G., and L. C. Routh. 2003. Healing Anxiety and Depression. New York: Putnam.
Антидепрессивный эффект физических упражнений
Babyak, M., J. A. Blumenthal, S. Herman, et al. 2000. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine 62(5): 633–638.
Blumenthal, J. A., M. A. Babyak, P. M. Doraiswamy, et al. 2007. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosomatic Medicine 69(7): 587–596.
Kessler, R. С., P. A. Berglund, O. Dernier, et al. 2005. Lifetime prevalence and ageof-onset distributions of DSM- IV disorders in the National Comorbidity Survey Replication (NCS- R). Archives of General Psychiatry 62(6): 593–602.
ГАМК
Abdou, А. М., S. Higashiguchi, К. Horie, et al. 2006. Relaxation and immunity enhancement effects of gamma- aminobutyric acid (GABA) administration in humans. Biofactors 26(3): 201–208.
Cocito, L., A. Bianchetti, L. Bossi, et al. 1994. GABA 30 and phosphati-dylserine in human photosensitivity: A pilot study. Epilepsy Research 17: 49–53.
Green, M. L., R. G. Green, and W. Santoro. 1988. Daily relaxation modifies serum and salivary immunoglobulins and psychophysi-ologic symptom severity. Biofeedback &. Self Regulation 13: 187–199.
Loeb, С., E. Benassi, G. P. Bo, et al. 1987. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Research 1: 209–212.
Гипербарическая оксигенация
Hopkins, R. О., L. К. Weaver, К. J. Valentine, et al. 2007. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. American Journal of Respiratory and Critical Care Medicine 176(10): 1001–1006.
Lo, C. P., S. Y. Chen, M. C. Chou. 2007. Diffusion- tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. European Journal of Neurology 14(7): 777–782.
Инозитол
Barak, Y., J. Levine, A. Glasman, et al. 1996. Inositol treatment of Alzheimer’s disease: a double-blind, cross- over placebo controlled trial. Progress in europsychopharmacology and Biological Psychiatry 20(4): 729–735.
Carey, Р. D., J. Warwick, В. Н. Harvey, et al. 2004. Single photon emission computed tomography (SPECT) in obsessive- compulsive disorder before and after treatment with inositol. Metabolic Brain Disease 19(1–2): 125–134.
Chengappa, K. N., J. Levine, S. Gershon, et al. 2000. Inositol as an addon treatment for bipolar depression. Bipolar Disorders 2(1): 47–55.
Fux, M., J. Levine, A. Aviv, et al. 1996. Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry 153(9): 1219–1221.
Кава-кава
Attele, A. S., J. T. Xie, C. S. Yuan. 2000. Treatment of insomnia: an alternative approach. Alternative Medicine Review 5(3): 249–259.
Basch, E., C. Ulbricht, P. Hammerness, et al. 2002. Kava monograph. Journal of Herbal Pharmacotherapy 2(4): 65–91.
Boerner, R. J., and S. Klement. 2004. Attenuation of neuroleptic- induced extrapyramidal side effects by Kava special extract WS 1490. Wiener Medizin i — sche Wochenschrift 154(21–22): 508–510.
Pittler, M. H., and E. Ernst. 2003. Kava extract for treating anxiety. Cochrane Database of Systatic Reviews Issue 1. Art. No.: CD003383. DOI: 10. 1002/14651858. CD003383.
Scherer, J. 1998. Kava-kava extract in anxiety disorders: an outpatient observational study. Advances in Therapy 15(4): 261–269.
Кетогенная диета для эпилепсии и других психиатрических расстройств.
Farasat, S., Е. Н. Kossoff, D. J. Pillas, et al. 2006. The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy & Behavior 2006 8(2): 406–410.
Kossoff, Е. Н., L. С. Laux, R. Blackford, et al. 2008. When do seizures usually improve with the ketogenic diet? Epilepsia 49(2): 329–333.
Martinez, C. G, P. L. Pyzik, and E. H. Kossoff. 2007. Discontinuing the ketogenic diet in seizure- free children: recurrence and risk factors. Epilepsia 48(1): 187–190.
Neal, E. G., H. Chaffe, R. H. Schwartz, et al. 2008. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurology 7(6): 500–506.
Аутизм
Evangeliou, A., I. Vlachonikolis, H. Mihailidou, et al. 2003. Application of a ketogenic diet in children with autistic behavior: pilot study. Journal of Child Neurology 18(2): 113–118.
Поведение
Murphy, P, S. S. Likhodii, M. Hatamian, et al. 2005. Effect of the ketogenic diet on the activity level of Wistar rats. Pediatric Research 57(3): 353–357.
Pulsifer, M. B., J. M. Gordon, J. Brandt, et al. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Developmental Medicine & Child Neurology 43(5): 301–306.
Биполярное расстройство
El — Mallakh, R. S., and M. E. Paskitti. 2001. The ketogenic diet may have moodstabilizing properties. Medical Hypotheses 57(6): 724–726.
Yaroslavsky, Y., Z. Stahl, and R. H. Belmaker. 2002. Ketogenic diet in bipolar illness. Bipolar Disorders 4(1): 75.
Жирные кислоты омега-3/рыбий жир и депрессия
Conklin, S. М., S. В. Manuck, J. К. Yao, et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosomatic Medicine 69(9): 932–934.
Grenyer, В. Е, Т Crowe, В. Meyer, et al. 2007. Fish oil supplementation in the treatment of major depression: a randomised double- blind placebocontrolled trial. Progress in Neuropsychopharmacology and Biological Psychiatry 31(7): 1393–1396.
Stoll, A. L., C. A. Locke, L. B. Marangell, et al. 1999. Omega-3 fatty acids and bipolar disorder: A review. Prostaglandins, Leukotrienes & Essential Fatty Acids 60(5–6): 329–337.
Валериана
Balderer, G., and A. A. Borbely. 1985. Effect of valerian on human sleep. Psychopharmacology 87(4): 406–409.
Coxeter, P. D., P. J. Schluter, H. L. Eastwood, et al. 2003. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n- of- 1 trials. Complementary Therapies in Medicine 11(4): 215–222.
Diaper, A., and I. Hindmarch. 2004. A double- blind, placebo- controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep- disturbed older adults. Phytotherapy Research 18(10): 831–836.
Kuhlmann, J., W. Berger, H. Podzuweit, et al. 1999. The influence of valerian treatment on «reaction time, alertness and concentration» in volunteers. Pharmacopsychiatry 32(6): 235–241.
Витамин D и депрессия
Armstrong, D. J., G. K. Meenagh, I. Bickle, et al. 2007. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clinical Rheumatology 26(4): 551–554.
Berk, M., К. M. Sanders, J. A. Pasco, et al. 2007. Vitamin D deficiency may play a role in depression. Medical Hypotheses 69(6): 1316–1319.
Wilkins, С. Н., Y. I. Sheline, С. М. Roe, et al. 2006. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. American Journal of Geriatric Psychiatry 14(12): 1032–1040.
Глава 8
Гинкго билоба
Burns, N., J. Bryan, and T. Nettelbeck. 2006. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Human Psychopharmacology 21(1): 27–37.
Dodge, H., T. Zitzelberger, B. Oken, et al. 2008. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70(19): 1809–1817.
Hartley, D., L. Heinze, S. Elsabagh, et al. 2003. Effects on cognition and mood in postmenopausal women of 1- week treatment with Ginkgo biloba. Pharmacology Biochemistry and Behavior 75(3): 711–720.
Le Bars, P. L. 2003. Response patterns of EGb 761 in Alzheimer’s disease: influence of neuropsychological profiles. Pharmacopsychiatry 36(Suppl. 1): S50-55.
Le Bars, P. L., and J. Kastelan. 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutrition 3(4A): 495–499.
Mix, J., and W. Crews. 2002. A double- blind, placebo- controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings. Human Psychopharmacology 17(6): 267–277.
Nathan, P, S. Tanner, J. Lloyd, et al. 2004. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans. Human Psychopharmacology 19(2): 91–96.
Singh, В., Н. Song, X. Liu, et al. 2004. Dangshen (Codonopsis pilosula) and Bai guo (Ginkgo biloba) enhance learning and memory. Alternative Therapies in Health & Medicine 10(4): 52–56.
Гюперзин A
Aisen, P. 2007. A multi- center, double- blind, placebo- controlled therapeutic trial to determine whether natural huperzine A improves cognitive function. Clinical Trials.
Ved, H., M. Koenig, J. Dave, et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8(4): 963–967.
Xu, S., Z. Cai, Z. Qu, et al. 1999. Huperzine- A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 20(6): 486–490.
Zhang, R., X. Tang Y. Han, et al. 1991. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 12(3): 250–252.
Мелатонин
Almeida Montes, L. G., M. P. Ontiveros Uribe, S. J. Cortes, et al. 2003. Treatment of primary insomnia with melatonin: A double- blind, placebo- controlled, crossover study. Journal of Psychiatry & Neuroscience 28(3): 191–196.
Cardinali, D. P, E. Gvozdenovich, and M. R. Kaplan. 2002. A doubleblind placebo-controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuroendocrinology Letters 23(1): 55–60.
Dowling, G. A., R. L. Burr, E. J. Van Someren, et al. 2008. Melatonin and brightlight treatment for rest- activity disruption in institutionalized patients with Alzheimer’s disease. Journal of the American Geriatrics Society 56(2): 239–246.
Pillar, G., Е. Shahar, N. Peled, et al. 2000. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatric Neurology 23(3): 225–228.
Smits, M. G., E. E. Nagtegaal, H. J. van der, et al. 2001. Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial. Journal of Child Neurology 16(2): 86–92.
Фосфатидилсерин
Crook, T., W. Petrie, C. Wells, et al. 1992. Effects of phosphatidyl-serine in Alzheimer’s disease. Psychopharmacology Bulletin 28: 61–66.
Hellhammer, J., E. Fries, C. Buss, et al. 2004. Effects of soy lecithin phos-phatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 7: 119–126.
Jorissen, B. L., F. Brouns, M. P. Van Boxtel, et al. 2001. The influence of soy- derived phosphatidylserine on cognition in age- associated memory impairment. Nutritional Neuroscience 4: 121–134.
Palmieri, G., R. Palmieri, M. R. Inzoli, et al. 1987. Double- blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clinical Trials 24: 73–83.
Винпоцетин
Balestreri, R., L. Fontana, and F. Astengo. 1987. A double- blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. Journal of the American Geriatrics Society 35(5): 425–430.
Bereczki, D., and I. Fekete. 1999. A systematic review of vinpocetine therapy in acute ischaemic stroke. European Journal of Clinical Pharmacology 55(5): 349–352.
Gulyas, В., С. Halldin, Р. Karlsson, et al. 1999. Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies, [in Hungarian] . Orvusi Hetilap 140(30): 1687–1691.
Vas, A., B. Gulyas, Z. Szabo, et al. 2002. Clinical and non- clinical investigations using positron emission tomography, near infrared spectroscopy and trans — cranial Doppler methods on the neuroprotective drug vinpocetine: A summary of evidences. Journal of Neurological Science 203–204: 259–262.
Глава 9
Aron, A., H. Fisher, D. J., et al. 2005. Reward, motivation, and emotion systems associated with early- stage intense romantic love. Journal of Neurophysiology 94(1): 327–337.
Fisher, H., A. Aron, and L. L. Brown. 2005. Romantic love: An fMRI study of a neural mechanism for mate choice. Journal of Comparative Neurology 493(1): 58–62.
Fisher, H. E., A. Aron, D. Mashek, et al. 2002. Defining the brain systems of lust, romantic attraction, and attachment. Archives of Sexual Behavior 31(5): 413–419.
Volkow, N. D., G. J. Wang, J. S. Fowler, et al. 1999. Association of meth-ylphenidateinduced craving with changes in right striato- orbito-frontal metabolism in cocaine abusers: Implications in addiction. American Journal of Psychiatry 156(1): 19–26.
Глава 11
Baxter, L. R., Jr., J. M. Schwartz, K. S. Bergman, et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessivecompulsive disorder. Archives of General Psychiatry 49(9): 681–689.
Brody, A. L., S. Saxena, J. M. Schwartz, et al. 1998. FDG- PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research 84(1): 1–6.
Глава 12
George, М. S., Т. A. Ketter, Р. I. Parekh, et al. 1995. Brain activity during transient sadness and happiness in healthy women. American Journal of Psychiatry 152(3): 341–351.
Katie, B., and S. Mitchell. 2002. Loving What Is. New York: Harmony.
Lee Duckworth, A., T A. Steen, and M. E. Seligman. 2005. Positive psychology in clinical practice. Annual Review of Clinical Psychology 1: 629–651.
Nelson, N. 2003. Power of Appreciation: The Key to a Vibrant Life. New York: Pocket.
Szloboda, P. 2008. Gratitude practices: A key to resiliency, well- being & happiness. Beginnings 28(1): 6–7.
Глава 14
Abramson, L. Y., M. E. P. Seligman, and J. D. Teasdale. 1978. Learned helplessness in humans — critique and reformulation. Journal of Abnormal Psychology 87: 49–74.
Amat, J., E. Paul, C. Zarza, et al. 2006. Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: Role of the ventral medial prefrontal cortex. Journal of Neuroscience 26: 13264-13272.
Bolognini, M., B. Plancherel, J. Laget, et al. 2003. Adolescents suicide attempts: Populations at risk, vulnerability, and substance use. Substance Use & Misuse 38(11–13): 1651–1669.
Koepp, M. J., R. N. Gunn, A. D. Lawrence, et al. 1998. Evidence for striatal dopamine release during a video game. Nature 393(6682): 266–268.
Sauzier, М. 1998. Disclosure of child sexual abuse. For better or for worse. Psychiatric Clinics of North America 12(2): 455–469.
Southwick, S. M., M. Vythilingam, and D. S. Charney. 2005. The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annual Review of Clinical Psychology 1: 255–291.
Valliant, G. 1998. Adaptation to Life. Cambridge, MA: Harvard University Press.
Глава 15
Klerman, G., M. M. Weissman, B. Rounsaville, et al. 1984. Interpersonal Psychotherapy of Depression. New York: Basic Books.
Oberman, L. M., V. S. Ramachandran, and J. A. Pineda. 2008. Modulation of mu suppression in children with autism spectrum disorders in response to familiar or unfamiliar stimuli: The mirror neuron hypothesis. Neuropsychologia 46(5): 1558–1565.
Ornish, D. 1998. Love and Survival. New York: HarperCollins.
Rizzolatti, G., and C. Sinigaglia. 2007. Mirror neurons and motor intentional ity. Functional Neurology 22(4): 205–210.
Weisman, M., J. Markowitz, and G. Klerman. 2007. Clinicians Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press.
Глава 16
Berns, G. 2006. Satisfaction: Sensation Seeking, Novelty, and the Science of Finding True Fulfillment. New York: Henry Holt.
Csikszentmihalyi, M. 1990. Flow: The Psychology of Optimal Experience. New York: HarperCollins.
Offer, D., Е. Ostrov, К. I. Howard, et al. 1990. Normality and adolescence. Psychiatric Clinics of North America 13(3): 377–388.
Rilling, J., D. Gutman, T. Zeh, et al. 2002. A neural basis for social cooperation. Neuron 35(2): 395–405.
Rilling, J. K., D. E. Dagenais, D. R. Goldsmith, et al. In press. Social cognitive neural networks during in- group and out- group interactions. Neuroimage.
Wood, R. M., J. K. Rilling and A. G. Sanfey. 2006. Effects of tryptophan depletion on the performance of an iterated Prisoners Dilemma game in healthy adults. Neuropsychopharmacology 31(5): 1075–1084.
Глава 17
Kosfeld, M., M. Heinrichs, P. J. Zak, et al. 2005. Oxytocin increases trust in humans. Nature 435(7042): 673–676.
Raine, A., T. Lencz, S. Bihrle, et al. 2000. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Archives of General Psychiatry 57(2): 119–127.
Данный текст является ознакомительным фрагментом.